Michael Joshua Rosen, MD
Pediatric Gastroenterology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Rosen’s office at (650) 497-8000 to ask if they take your plan before you enroll.
California Medical Board record
Licence C173859 · Current
Licensed to practise in California · since 2021 · expires 2027-07-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Pediatrics - Pediatric Gastroenterology
Medicaid work
$7,023 in 2021
Medicaid paid $7,023 for 202 billed services this clinician did in 2021, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 125 | $4,825 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 77 | $2,198 |
| 2021 | 202 | 2 | 15 | $7,023 |
| 2020 | 100 | 2 | 21 | $4,392 |
| 2019 | 138 | 2 | 19 | $3,985 |
| 2018 | 45 | 1 | 13 | $1,687 |
See the largest Medicaid services in earlier years
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 85 | $3,393 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 15 | $999 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 96 | $3,117 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 42 | $868 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 45 | $1,687 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 25 Part D prescriptions in 2020. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2021 | 14 | None | None | None | $6,032 |
| 2020 | 25 | None | 0% (0) | None | $12,197 |
| 2019 | 25 | None | 0% (0) | None | $12,031 |
| 2018 | 26 | None | 0% (0) | 42% | $12,629 |
| 2017 | 40 | None | 0% (0) | None | $13,299 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2018: 1 drug
| Pentasa | 11 | $12,190 | $1,108 |
2017: 2 drugs
| Esomeprazole Magnesium | 12 | $6,566 | $547 |
| Cyproheptadine | 11 | $496 | $45 |
Money from drug and device companies
$16,529 in 2025
| 2025 | 2 | 13 | $15,200 | $16,529 |
| 2024 | 1 | 1 | None | $31 |
| 2023 | 2 | 2 | $3,610 | $3,610 |
| 2021 | 1 | 1 | $3,000 | $3,000 |
| 2020 | 2 | 2 | None | $200 |
| 2019 | 2 | 3 | $3,200 | $3,348 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mesoblast | Ryoncil | $15,200 | 4 payments
|
| Boston Scientific | Spyglass | $1,329 | 9 payments
|
See all 13 published payments
| Mesoblast | Consulting · 2025-11-26 | Ryoncil | $3,600 |
| Mesoblast | Consulting · 2025-09-30 | Ryoncil | $2,400 |
| Mesoblast | Consulting · 2025-08-29 | Ryoncil | $2,400 |
| Boston Scientific | Travel · 2025-08-16 | Spyglass | $353 |
| Boston Scientific | Meals · 2025-08-16 | Spyglass | $78 |
| Boston Scientific | Meals · 2025-08-15 | Spyglass | $82 |
| Boston Scientific | Meals · 2025-08-15 | Spyglass | $76 |
| Boston Scientific | Travel · 2025-08-15 | Spyglass | $183 |
| Boston Scientific | Travel · 2025-08-15 | Spyglass | $136 |
| Boston Scientific | Travel · 2025-08-14 | Spyglass | $183 |
| Boston Scientific | Travel · 2025-08-14 | Spyglass | $23 |
| Boston Scientific | Travel · 2025-08-14 | Spyglass | $215 |
| Mesoblast | Consulting · 2025-07-02 | Ryoncil | $6,800 |
See earlier years (2024, 2023, 2021, 2020, 2019)
2024: $31
| Genzyme | Dupixent | $31 | 1 payment
|
2023: $3,610
| Pfizer | Xeljanz | $3,000 | 1 payment
|
| Fresenius Kabi USA | Idacio | $610 | 1 payment
|
2021: $3,000
| Pfizer | Xeljanz | $3,000 | 1 payment
|
2020: $200
| Davol | Phasix | $163 | 1 payment
|
| AbbVie | Humira | $37 | 1 payment
|
2019: $3,348
| Pacira Pharmaceuticals | Exparel | $3,200 | 1 payment
|
| AbbVie | Humira | $148 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| PFIZER INC. · Openlabel Induction and Maintenance Study of Oral Cp690550 Tofacitinib in Children With Moderately To Severely Active Ulcerative Colitis · 2025 | Their institution | $185,328 |
| PFIZER INC. · Openlabel Induction and Maintenance Study of Oral Cp690550 Tofacitinib in Children With Moderately To Severely Active Ulcerative Colitis · 2023 | Their institution | $54,219 |
| PFIZER INC. · Openlabel Induction and Maintenance Study of Oral Cp690550 Tofacitinib in Children With Moderately To Severely Active Ulcerative Colitis · 2021 | Their institution | $26,500 |
Professional record
- NPI
- 1073660890
- Licence
- CA C173859, OH 35.122054, TN 477HWQCalifornia C173859: Current · expires 2027-07-31
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2080P0206X (2080P0206X); Pediatrics (208000000X)
- Mailing address
- 725 Welch Rd, Palo Alto, CA, 94304
- NPI first listed
- 2007-01-04
- NPI last updated
- 2024-04-10
- NPI record certified
- 2024-04-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3333 Burnet Ave, Cincinnati, OH, 45229